At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
KURE KraneShares MSCI All China Health Care Index ETF
Market Closed 11-13 16:00:00 EST
18.11
-0.19
-1.04%
盘后18.11
+0.000.00%
16:15 EST
High18.23Low18.02Vol20.07K
Open18.17D1 Closing18.30Amplitude1.14%
Mkt Cap111.36MTradable Cap111.36MTotal Shares6.15M
T/O363.70KT/O Rate0.33%Tradable Shares6.15M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Several GLP-1 Injectables Enter National Basic Medical Insurance List for the First Time, Including Pfizer and Innovent Bio Products, for Treating Adults with Type 2 Diabetes
Deep News  ·  60 minutes ago
Several GLP-1 Injectables Enter National Basic Medical Insurance List for the First Time, Including Pfizer and Innovent Bio Products, for Treating Adults with Type 2 Diabetes
Innovent Announces Seven Innovative Products Including Mazdutide and Pecondle® Successfully Included in the 2026 National Reimbursement Drug List
THOMSON REUTERS  ·  11:48
Innovent Announces Seven Innovative Products Including Mazdutide and Pecondle® Successfully Included in the 2026 National Reimbursement Drug List
Innostar Bio-Tech Chair Chang Yan: Value of Chinese Innovative Drug Assets Keeps Growing, Large-Scale AI Applications Expected Within Two to Three Years
Deep News  ·  11-13 18:50
Innostar Bio-Tech Chair Chang Yan: Value of Chinese Innovative Drug Assets Keeps Growing, Large-Scale AI Applications Expected Within Two to Three Years
Baili Tianheng Chairman Zhu Yi: China's Structural Edge in Innovative Drugs Is Being Globally Validated and Will Remain Competitive Over the Next Decade
Deep News  ·  11-13 17:31
Baili Tianheng Chairman Zhu Yi: China's Structural Edge in Innovative Drugs Is Being Globally Validated and Will Remain Competitive Over the Next Decade
CSPC Pharmaceutical Group Stock Falls 4.3% in Hong Kong, Underperforms Competitors
Dow Jones  ·  11-13 16:31
CSPC Pharmaceutical Group Stock Falls 4.3% in Hong Kong, Underperforms Competitors
Wuxi Biologics (Cayman) Stock Slides 4.4% in Hong Kong
Dow Jones  ·  11-13 16:30
Wuxi Biologics (Cayman) Stock Slides 4.4% in Hong Kong
CITIC CLSA Raises INNOVENT BIO (01801) Target Price to HK$152, Maintains Outperform Rating
Stock News  ·  11-13 14:24
CITIC CLSA Raises INNOVENT BIO (01801) Target Price to HK$152, Maintains Outperform Rating
Hong Kong Corporate Earnings Week Ahead
Reuters  ·  11-13 12:00
Hong Kong Corporate Earnings Week Ahead
Innovent Reports Preclinical Data Showing Iar177 Outperforms Single-Target Blockade in Rheumatoid Arthritis Models
Reuters  ·  11-13 08:00
Innovent Reports Preclinical Data Showing Iar177 Outperforms Single-Target Blockade in Rheumatoid Arthritis Models
Breakingviews-China Emerges as Obesity Drug Lab for Big Pharma
Reuters  ·  11-12 20:00
Breakingviews-China Emerges as Obesity Drug Lab for Big Pharma
Australian pension fund CIO Ben Squires: Chinese biotech firms now rank among world's best, bullish on long-term opportunities in Chinese assets
Deep News  ·  11-12 16:11
Australian pension fund CIO Ben Squires: Chinese biotech firms now rank among world's best, bullish on long-term opportunities in Chinese assets
BeiGene (06160) Jumps Over 3% in Morning Trade as Company Raises Full-Year Revenue Guidance for Third Time This Year, Innovation Pipeline Nears Fruition
Stock News  ·  11-12 11:50
BeiGene (06160) Jumps Over 3% in Morning Trade as Company Raises Full-Year Revenue Guidance for Third Time This Year, Innovation Pipeline Nears Fruition
BeOne Medicines Sees HK$32.786 Billion in Custodied Shares as Shareholder Deposits 130 Million Shares with Citibank
Stock News  ·  11-12 08:16
BeOne Medicines Sees HK$32.786 Billion in Custodied Shares as Shareholder Deposits 130 Million Shares with Citibank
What WuXi Biologics Bulls Got Right
Simply Wall St.  ·  11-11 18:22
What WuXi Biologics Bulls Got Right
CSPC Pharmaceutical Group Stock Falls 1.1% in Hong Kong
Dow Jones  ·  11-11 16:33
CSPC Pharmaceutical Group Stock Falls 1.1% in Hong Kong
Sinolink Securities: Chinese innovative drug companies deliver standout results, potentially spurring a new wave of overseas expansion opportunities
Stock News  ·  11-11
Sinolink Securities: Chinese innovative drug companies deliver standout results, potentially spurring a new wave of overseas expansion opportunities
Wuxi Biologics (Cayman) Stock Rallies 1.4% in Hong Kong
Dow Jones  ·  11-10
Wuxi Biologics (Cayman) Stock Rallies 1.4% in Hong Kong
CSPC Pharmaceutical Group Stock Rallies 2.3% in Hong Kong
Dow Jones  ·  11-10
CSPC Pharmaceutical Group Stock Rallies 2.3% in Hong Kong
Innovent Bio Rises Over 3% as CREDIT-5 Phase III Trial of Sinitilimab Injection Meets Primary Endpoint in Hyperlipidemia Treatment
Stock News  ·  11-10
Innovent Bio Rises Over 3% as CREDIT-5 Phase III Trial of Sinitilimab Injection Meets Primary Endpoint in Hyperlipidemia Treatment
Daiwa Raises BeiGene (06160) Price Target to HK$286, Q3 Results Beat Expectations Again
Stock News  ·  11-10
Daiwa Raises BeiGene (06160) Price Target to HK$286, Q3 Results Beat Expectations Again

Introduction

Company Name.
KraneShares MSCI All China Health Care Index ETF
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in instruments in its underlying index or in instruments that have economic characteristics similar to those in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Issue price:
--